Genotyping and monitoring of circulating tumor DNA in lung cancer patients during the early period of EGFR-TKI treatment using deep sequencing.
The new classifications included several major changes and may help identify different subtypes. The fifth edition of the World Health Organization classification (2022 WHO) and the International ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback